AVADEL PHARMACEUTICALS PLC Balance Sheet
AVDL / Health Care|12 years of annual SEC 10-K data (FY2013-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
AVADEL PHARMACEUTICALS PLC had $164M in total assets and $74M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.4M | $31.2M | $74.0M | $50.7M | $71.7M | $9.8M | $9.3M | $16.6M | $39.2M | $65.1M | $39.8M | $6.6M |
| Accounts Receivable | $34.1M | $12.1M | $0 | - | $0 | $8.3M | $11.3M | $14.8M | $17.8M | $7.5M | $1.7M | - |
| Inventory | $20.3M | $10.4M | $0 | - | $0 | $3.6M | $4.8M | $6.2M | $3.3M | $3.7M | $6.7M | - |
| Current Assets | $134.2M | $134.2M | $100.8M | $192.5M | $263.5M | $82.4M | $124.9M | $124.0M | $181.2M | $166.4M | $112.3M | - |
| PP&E (Net) | $453.0K | $585.0K | $839.0K | $285.0K | $359.0K | $544.0K | $1.9M | $3.0M | $3.3M | $2.6M | $1.8M | - |
| Goodwill | $16.8M | $16.8M | $16.8M | $16.8M | $16.8M | $18.5M | $18.5M | $18.5M | $18.5M | $18.5M | $18.5M | - |
| Total Assets | $164.2M | $164.7M | $132.8M | $247.3M | $311.6M | $151.4M | $190.3M | $253.3M | $245.5M | $215.1M | $174.2M | - |
| Current Liabilities | $48.8M | $36.9M | $55.8M | $21.0M | $15.1M | $36.0M | $38.4M | $86.5M | $62.4M | $45.2M | $70.8M | - |
| Total Debt | - | - | $91.6M | $142.4M | $128.2M | $121.7M | $115.8M | $267.0K | $547.0K | $684.0K | $1.3M | - |
| Shareholders' Equity | $73.8M | $87.7M | -$21.1M | $78.2M | $162.3M | -$29.2M | $2.8M | $85.6M | $42.1M | $69.1M | $25.0M | -$8.8M |